PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32487989-6	2020	In cultured podocytes, exposure to high ambient glucose amplified HuR expression and repressed TTP expression, upregulated IL-17 and claudin-1, and promoted podocyte injury.	Glucose	48-55	interleukin 17A	Mus musculus	123-128	
33796910-14	2021	Glucose-stimulated insulin secretion was similar between isolated islets derived from FL and KO mice, but was reduced by IL-17A treatment.	Glucose	0-7	interleukin 17A	Mus musculus	121-127	
33603662-13	2020	Meanwhile, anthocyanin reduced the expression of IL-17 in high-glucose-treated cardiac fibroblasts and exhibited an anti-inflammatory effect.	Glucose	63-70	interleukin 17A	Mus musculus	49-54	
34394978-6	2021	Lopes and colleagues show that, in a murine context, low glucose environments preferentially retained pro-tumorigenic IL-17-producing gammadeltaT cells.	Glucose	57-64	interleukin 17A	Mus musculus	118-123	
28237848-11	2017	Loss of IL-17 deficiency improves diet-induced obesity, fatty liver, glucose and lipid metabolism in mice.	Glucose	69-76	interleukin 17A	Mus musculus	8-13	
29305939-5	2018	High glucose treatment induced collagen production were abolished in cultured IL-17 knockout cardiac fibroblasts (CFs).	Glucose	5-12	interleukin 17A	Mus musculus	78-83	
29305939-7	2018	Knockout of IL-17 abrogated high glucose induced upregulation of AK081284.	Glucose	33-40	interleukin 17A	Mus musculus	12-17	
29305939-11	2018	The IL-17/AK081284/TGFbeta1 signaling pathway mediates high glucose induced collagen production.	Glucose	60-67	interleukin 17A	Mus musculus	4-9	
28237848-14	2017	IL-17 inhibits adipogenesis where a lack of IL-17 ameliorates glucose metabolism.	Glucose	62-69	interleukin 17A	Mus musculus	44-49	
26562537-0	2016	Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway.	Glucose	162-169	interleukin 17A	Mus musculus	25-40	
26562537-6	2016	Unexpectedly, IL-17A-in-Brain mice show decreases in body weight and adipose tissue mass and an improvement in glucose tolerance and insulin sensitivity.	Glucose	111-118	interleukin 17A	Mus musculus	14-20	
26562537-8	2016	Our results provide direct evidence for the first time that IL-17A overexpression in the central nervous system does not cause physical and learning disabilities and neuroinflammation and suggest that IL-17A may regulate glucose metabolism through the AKT signaling pathway.	Glucose	221-228	interleukin 17A	Mus musculus	201-207	
21037091-6	2010	IL-17 also acts on differentiated adipocytes, impairing glucose uptake, and young IL-17-deficient mice show enhanced glucose tolerance and insulin sensitivity.	Glucose	56-63	interleukin 17A	Mus musculus	0-5	
26608911-7	2016	Blocking glucose oxidation inhibited both IFN-gamma and IL-17 production, which could not be achieved by blocking pyruvate reduction.	Glucose	9-16	interleukin 17A	Mus musculus	56-61	
22184328-9	2012	Treatment of KK-Ay mice with anti-IL-17 antibody significantly increased 2-[(3)H]deoxy-d-glucose uptake in skeletal muscle but not in white adipose tissue and attenuated the increase in blood glucose level after a glucose load.	Glucose	89-96	interleukin 17A	Mus musculus	34-39	
18310510-1	2008	We investigated the expression of the proinflammatory cytokine interleukin (IL)-17 in cardiac fibroblasts and its induction by high glucose (HG).	Glucose	132-139	interleukin 17A	Mus musculus	63-82